Ocriplasmin successful against vitreomacular adhesion: study

Two phase III studies of ocriplasmin (ThromboGenics) have found that the truncated form of the human serine protease plasmin significantly resolved vitreomacular traction and closed macular holes compared with placebo in patients with vitreomacular adhesion (VMA), according to findings published in the New England Journal of Medicine.

Full Story →